Encompass Health (NYSE:EHC) Releases Quarterly Earnings Results

Encompass Health (NYSE:EHC) released its quarterly earnings data on Monday. The company reported $1.11 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.10, Briefing.com reports. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The business had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.30 billion. During the same period last year, the company posted $0.95 EPS. The company’s revenue was up 9.6% compared to the same quarter last year. Encompass Health updated its FY24 guidance to $3.97-$4.22 EPS.

Encompass Health Stock Up 1.1 %

Shares of NYSE EHC traded up $0.90 during trading hours on Wednesday, hitting $85.58. The stock had a trading volume of 212,165 shares, compared to its average volume of 653,581. The company has a market capitalization of $8.62 billion, a P/E ratio of 22.90, a P/E/G ratio of 1.45 and a beta of 0.89. The firm’s 50-day moving average price is $86.45 and its two-hundred day moving average price is $81.34. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.37 and a current ratio of 1.37. Encompass Health has a 52 week low of $57.55 and a 52 week high of $94.38.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.79%. This is a positive change from Encompass Health’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, October 1st. Encompass Health’s payout ratio is currently 18.38%.

Insider Buying and Selling at Encompass Health

In other news, insider Elissa Joy Charbonneau sold 10,000 shares of the stock in a transaction on Friday, May 24th. The shares were sold at an average price of $85.02, for a total transaction of $850,200.00. Following the transaction, the insider now owns 18,594 shares in the company, valued at approximately $1,580,861.88. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 2.10% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on EHC shares. Royal Bank of Canada raised their target price on shares of Encompass Health from $83.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, May 22nd. Stephens reissued an “overweight” rating and set a $105.00 target price on shares of Encompass Health in a research note on Tuesday. Barclays decreased their target price on Encompass Health from $113.00 to $109.00 and set an “overweight” rating for the company in a research report on Tuesday. Leerink Partnrs raised Encompass Health to a “strong-buy” rating in a research report on Wednesday, July 10th. Finally, Truist Financial raised their price objective on Encompass Health from $95.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, July 15th. Eight equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and an average price target of $99.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.